Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.48
-0.15 (-2.26%)
At close: Jun 8, 2026, 4:00 PM EDT
6.48
0.00 (0.00%)
After-hours: Jun 8, 2026, 4:01 PM EDT
Aura Biosciences Employees
Aura Biosciences had 113 employees as of December 31, 2025. The number of employees increased by 4 or 3.67% compared to the previous year.
Employees
113
Change (1Y)
4
Growth (1Y)
3.67%
Revenue / Employee
n/a
Profits / Employee
-$994,628
Market Cap
716.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 113 | 4 | 3.67% | 113 | 0 |
| Dec 31, 2024 | 109 | 20 | 22.47% | 106 | 3 |
| Dec 31, 2023 | 89 | 17 | 23.61% | 88 | 1 |
| Dec 31, 2022 | 72 | 20 | 38.46% | 70 | 2 |
| Dec 31, 2021 | 52 | - | - | 52 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Kura Oncology | 260 |
| Geron | 258 |
| Omeros | 175 |
| Sana Biotechnology | 142 |
| ORIC Pharmaceuticals | 104 |
| Vor Biopharma | 76 |
| Avalo Therapeutics | 33 |
AURA News
- 7 days ago - Aura Biosciences completes enrollment in belzupacap sarotalocan trial - TheFly
- 7 days ago - Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma - GlobeNewsWire
- 12 days ago - Aura Biosciences Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 19 days ago - Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Aura Biosciences Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 27 days ago - Aura Biosciences price target lowered to $17 from $26 at Leerink - TheFly
- 27 days ago - Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire